As Tylenol Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Finding that Acetaminophen Combined With Alcohol May Increase Risk for Kidney Damage

The Firm is investigating Tylenol lawsuits on behalf of individuals who suffered severe liver damage, allegedly due to acetaminophen in Tylenol –brand medications.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Free Case Review
Dozens of lawsuits are now pending in federal court that allege a link between the use of Tylenol and liver damage.

New York, NY (PRWEB) December 25, 2013

As Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) continue to mount in courts around the country, Bernstein Liebhard LLP notes that a new study has found that taking acetaminophen in combination with even small amounts of alcohol may be associated with an increased risk for kidney damage. According to a report from HealthDay News, the study, which was presented last month at the American Public Health Association's annual meeting in Boston, looked at data from more than 10,000 people who had been surveyed about their alcohol consumption, use of acetaminophen and health problems. Almost half of the respondents who reported combining acetaminophen with alcohol also reported kidney dysfunction. *

“Dozens of lawsuits are now pending in federal court that allege a link between the use of Tylenol and liver damage. This study is just a further reminder that the acetaminophen in these over-the-counter medications can often be associated with very serious side effects,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free legal reviews to individuals who may have suffered liver damage resulting in hospitalization, liver transplantation, or death, allegedly associated with the use of a Tylenol-brand medication.

Tylenol and Liver Damage
According to court documents, at least 100 Tylenol lawsuits alleging acetaminophen can cause liver damage, even when taken as directed, are currently pending in a multidistrict litigation now underway in U.S. District Court, Eastern District of Pennsylvania. All of these lawsuits similarly allege that Johnson & Johnson failed to provide consumers with adequate warnings about the potential effects of acetaminophen use on the liver, including liver failure and the need for a liver transplant. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)

According to the U.S. Food & Drug Administration (FDA), acetaminophen was the leading cause of acute liver failure in the U.S. between 1998 and 2003. From 1990 to 1998, acetaminophen was blamed for 56,000 emergency room visits, 26,000 hospitalizations, and 458 deaths annually. Two years ago, the FDA reduced the amount of acetaminophen that prescription drugs can contain to 325 milligrams per two pills. **

Johnson & Johnson announced over the summer it was adding more prominent, red-lettered warnings to the labels of Tylenol products regarding the potential for severe liver damage. According to a report from Bloomberg.com, Extra Strength Tylenol – which contains 500 milligrams of acetaminophen per tablet - was to appear with the warnings in October. The modified labels will begin appearing on other Tylenol-brand medications in the coming months.***

Individuals who suffered acetaminophen-induced liver damage resulting in hospitalization, liver transplantation or death allegedly associated with a Tylenol product may be entitled to compensation for medical expenses and other injury-related damages. Find out more about filing a Tylenol lawsuit by visiting Bernstein Liebhard LLP’s website. For a free evaluation of your claim, please call 800-511-5092.

*consumer.healthday.com/diseases-and-conditions-information-37/misc-kidney-problem-news-432/tylenol-alcohol-a-bad-mix-says-study-681768.html, HealthDay News, November 4, 2013
**fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm239894.htm, FDA, January 2011
***bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.tylenollawsuitclaims.com/
https://plus.google.com/115936073311125306742?rel=author